prostate cancer

Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis
Jens Klein, Kerstin Hofreuter-Gätgens, Daniel Lüdecke, Margit Fisch, Markus Graefen, Olaf von dem Knesebeck

BMJ Open Jun 2016, 6 (6) e010968; DOI: 10.1136/bmjopen-2015-010968
Community pharmacy lifestyle intervention to increase physical activity and improve cardiovascular health of men with prostate cancer: a phase II feasibility study
Agnieszka Lemanska, Karen Poole, Bruce A Griffin, Ralph Manders, John M Saxton, Lauren Turner, Joe Wainwright, Sara Faithfull

BMJ Open Jun 2019, 9 (6) e025114; DOI: 10.1136/bmjopen-2018-025114
NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (NeuroSAFE PROOF): protocol for a randomised controlled feasibility study
Eoin Dinneen, Aiman Haider, Clare Allen, Alex Freeman, Tim Briggs, Senthil Nathan, Chris Brew-Graves, Jack Grierson, Norman R Williams, Raj Persad, Neil Oakley, Jim M Adshead, Hartwig Huland, Alexander Haese, Greg Shaw

BMJ Open Jun 2019, 9 (6) e028132; DOI: 10.1136/bmjopen-2018-028132
Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
David Thurtle, Sabrina H Rossi, Brendan Berry, Paul Pharoah, Vincent J Gnanapragasam

BMJ Open Jun 2019, 9 (6) e029149; DOI: 10.1136/bmjopen-2019-029149
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
Thanya Pathirana, Andrew Hayen, Jenny Doust, Paul Glasziou, Katy Bell

BMJ Open Mar 2019, 9 (3) e022457; DOI: 10.1136/bmjopen-2018-022457
Interrupted versus continuous suturing for vesicourethral anastomosis during radical prostatectomy: protocol for a systematic review and meta-analysis
Karl Friedrich Kowalewski, Christian Tapking, Svetlana Hetjens, Felix Nickel, Philipp Mandel, Manuel Ritter, Maximilian Christian Kriegmair

BMJ Open Nov 2017, 7 (11) e019823; DOI: 10.1136/bmjopen-2017-019823
Cohort profile: the Martinique Cancer Registry and the quality of life prostate cancer cohort (QoL Prostate-MQ): challenges and prospects for reducing disparities in the Caribbean
Clarisse Joachim, Jacqueline Veronique-Baudin, Thierry Almont, Stephen Ulric-Gervaise, Jonathan Macni, Olivier Pierre-Louis, Lidvine Godaert, Moustapha Drame, Jean-Luc Novella, Karim Farid, Vincent Vinh-Hung, Patrick Escarmant

BMJ Open Jul 2018, 8 (7) e021540; DOI: 10.1136/bmjopen-2018-021540
Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
Robin W M Vernooij, Lyubov Lytvyn, Hector Pardo-Hernandez, Loai Albarqouni, Carlos Canelo-Aybar, Karen Campbell, Thomas Agoritsas

BMJ Open Sep 2018, 8 (9) e025470; DOI: 10.1136/bmjopen-2018-025470
Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
Danielle Crawley, Hans Garmo, Sarah Rudman, Pär Stattin, Björn Zethelius, Jo Armes, Lars Holmberg, Jan Adolfsson, Mieke Van Hemelrijck

BMJ Open Mar 2018, 8 (3) e020787; DOI: 10.1136/bmjopen-2017-020787
Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data
Samuel W D Merriel, Margaret T May, Richard M Martin

BMJ Open Jan 2018, 8 (1) e019409; DOI: 10.1136/bmjopen-2017-019409

Main menu

prostate cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

prostate cancer

Pages